A Severe Alzheimer’s Disease Patient Improved by Intravenous Mesenchymal Stem Cell Transplant
Alzheimer’s disease (AD) is a progressive neurological disorder and is the most common form of dementia. The terminal stage of AD is characterized by severe cognitive and substantial functional decline, requiring extensive assistance with daily activities. As effective therapies at this stage are no...
Saved in:
| Main Author: | Takahiro Honda Pazili |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Case Reports in Neurological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2024/8353492 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transplanted Bone Marrow Mesenchymal Stem Cells Improve Memory in Rat Models of Alzheimer's Disease
by: Parvin Babaei, et al.
Published: (2012-01-01) -
Mesenchymal stem cell application in Alzheimer's disease
by: Qianying Feng, et al.
Published: (2025-12-01) -
Mesenchymal Stem Cell Therapy for Alzheimer’s Disease
by: A. E. Hernández, et al.
Published: (2021-01-01) -
How to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart?
by: Liangpeng Li, et al.
Published: (2016-01-01) -
Exploration of Cytokines That Impact the Therapeutic Efficacy of Mesenchymal Stem Cells in Alzheimer’s Disease
by: Herui Wang, et al.
Published: (2025-06-01)